Clinical Trial Update: Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated whether erythropoietin improves survival and neurological outcomes in hypoxic ischemic encephalopathy. The study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hypoxic Ischemic Encephalopathy | Phase 3 | Status: COMPLETED